Bariatric and metabolic endoscopy: impact on obesity and related comorbidities | Zendy

Amit Mehta | Zendy; Reem Z. Sharaiha | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Bariatric and metabolic endoscopy: impact on obesity and related comorbidities

Author(s) -

Amit Mehta,

Reem Z. Sharaiha

Publication year - 2021

Publication title -

therapeutic advances in gastrointestinal endoscopy

Language(s) - English

Resource type - Journals

ISSN - 2631-7745

DOI - 10.1177/26317745211019156

Subject(s) - medicine , obesity , disease , pandemic , diabetes mellitus , metabolic syndrome , intensive care medicine , type 2 diabetes mellitus , type 2 diabetes , comorbidity , public health , general surgery , surgery , covid-19 , pathology , endocrinology , infectious disease (medical specialty)

The global obesity pandemic is among the most significant public health crises today. Furthermore, obesity remains a major risk factor for many weight-related comorbid conditions including cardiovascular disease, type 2 diabetes mellitus, liver disease, and cancer. Endoscopic bariatric therapies are currently on the rise as a new tool in the fight against the obesity epidemic, offering patients an alternative to more invasive surgery and a more effective option than diet and lifestyle modifications. The aim of this review article is to summarize the current literature regarding endoscopic bariatric therapies and their impact on obesity and its associated metabolic complications.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research